Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
IJKD-Iranian Journal of Kidney Diseases. 2009; 3 (3): 151-155
Dans Anglais | IMEMR | ID: emr-91263

Résumé

Purine metabolites constitute a major class of uremic toxins, and reliable characterization of which helps nephrologists to choose the most appropriate treatment for the patients individually. In the present study, we assessed plasma concentrations of hypoxanthine and uric acid as purine metabolites in patients on maintenance hemodialysis, before and after a dialysis session. A total of 20 patients on maintenance hemodialysis were enrolled in this study. All of the patients underwent a routine 4-hour dialysis, as scheduled 3 times per week. Polysulfone membranes and bicarbonate dialysis solution were used in all dialysis sessions. Blood specimens were taken from the arteriovenous fistula immediately before and after one hemodialysis session, in order to measure plasma concentrations of hypoxanthine and uric acid by high-performance liquid chromatography, and to compare the predialysis and postdialysis values. Before hemodialysis, the mean plasma hypoxanthine and uric acid concentrations were 18.93 +/- 8.28 micro mol/L and 44.16 +/- 22.88 micro mol/L, respectively. After hemodialysis, these concentrations reduced to 13.68 +/- 4.42 micro mol/L and 15.61 +/- 11.12 micro mol/L, respectively. Hypoxanthine concentration had a 27.7% decrease after hemodialysis [mean difference, 5.25 +/- 6.24 micro mol/L; 95% confidence interval, 2.32 to 8.10; P < .001]. Also, uric acid concentration decreased by 64.6% [mean difference, 28.55 +/- 14.39 micro mol/L; 95% confidence interval, 21.81 to 32.28; P < .001. Plasma concentrations of hypoxanthine and uric acid are higher than normal before hemodialysis, and they decrease significantly after hemodialysis; however, both of them may be still higher than normal values


Sujets)
Humains , Mâle , Femelle , Acide urique/sang , Dialyse rénale , Purines , Chromatographie en phase liquide à haute performance , Défaillance rénale chronique
SÉLECTION CITATIONS
Détails de la recherche